1 asset in Immunodeficiency-Associated Lymphoproliferative Disease
Therapeutic assets addressing Immunodeficiency-Associated Lymphoproliferative Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Thiscart19A Immunodeficiency-Associated Lymphoproliferative Disease | He Huang | P1 | CC (43) |